Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L23a pseudogene 6 (RPL23AP6)
- Target
- RPL23AP6
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L23a pseudogene 6 (RPL23AP6) is a processed pseudogene in the human genome, meaning it is a non-functional segment of DNA that is similar to the protein-coding gene for ribosomal protein L23a (RPL23A) but does not encode a protein product. Such pseudogenes are remnants of gene duplication or retrotransposition events and are generally transcriptionally inactive, lacking regulatory elements or containing disruptive mutations. RPL23AP6 is one of many pseudogenes related to the ribosomal protein gene family scattered throughout the genome. There is no evidence to support a functional protein product or a direct role as a drug target or disease biomarker at this time[4][8][7].
- Other names
- dJ1068F16.1RPL23A_36_1683RPL23AP6
02
Biological functions
Other (Pseudogenes do not encode functional proteins; any function is usually regulatory, if present)[4][8]
03
Disease associations
Other (No established disease role for RPL23AP6; functional ribosomal protein L23a is autoantigenic in rheumatoid arthritis, but not its pseudogenes[7][10])
Beyond the preview
Go deeper on Ribosomal protein L23a pseudogene 6 (RPL23AP6).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 6 (RPL23AP6).